News

A study has shown that active brain metastases in breast cancer patients can be regressed by a novel class of drug known as T-Dxd – a chemical conjugate of an antibody and a chemotherapy drug.

Collage is known to form a key part of the tumor microenvironment and new research has shown that it also triggers metastasis in breast cancer.

Researchers have used a zebrafish eye mutation to study the role of a protein in preventing cell death, which could have implications for the development of cancer therapies

An NMR method enhanced by a very powerful amplifier, in combination with molecular dynamics simulation, now enables protein detection and accurate characterization at physiological concentrations.

A collaborative research team has synthesized a molecule that could be used as an alternative to the antibodies used in immunotherapy treatment for cancer. The study is published in the Journal for ImmunoTherapy of Cancer.

Researchers have developed a powerful immunity-boosting postoperative hydrogel treatment that could improve the outlook for patients with glioblastoma.

Scientists say they have identified key molecular differences between cancer cells that cling to an initial tumor and those that venture off to form distant tumors.

Exposure to a common chemical in the PFAS family is linked to an increased risk of liver cancer, as confirmed in human samples.

New research suggests that people with elevated levels of the protein prostasin, which is mainly found in epithelial cells which line the surfaces and organs of the body, may be at higher risk of developing diabetes or dying from cancer.

T cells can become exhausted during cancer therapy and are no longer able to function properly. It was previously thought that exhausted T cells could not be revived, but new research indicates this is not the case.